Progyny, Inc. (PGNY)
NASDAQ: PGNY · Real-Time Price · USD
26.63
+0.47 (1.80%)
At close: Dec 19, 2025, 4:00 PM EST
27.00
+0.37 (1.39%)
After-hours: Dec 19, 2025, 7:58 PM EST
Progyny Market Cap
Progyny has a market cap or net worth of $2.3 billion as of December 19, 2025. Its market cap has increased by 81.19% in one year.
Market Cap
2.30B
Enterprise Value
1.98B
1-Year Change
81.19%
Ranking
Category
Stock Price
$26.63
Market Cap Chart
Since October 25, 2019, Progyny's market cap has increased from $1.31B to $2.30B, an increase of 75.27%. That is a compound annual growth rate of 9.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 2.30B | 56.30% |
| Dec 31, 2024 | 1.47B | -58.78% |
| Dec 29, 2023 | 3.56B | 23.15% |
| Dec 30, 2022 | 2.89B | -36.45% |
| Dec 31, 2021 | 4.55B | 23.98% |
| Dec 31, 2020 | 3.67B | 59.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 951.79B |
| Johnson & Johnson | 503.54B |
| AbbVie | 396.60B |
| UnitedHealth Group | 296.11B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 250.34B |
| Abbott Laboratories | 217.53B |